Glenmark Generics Inc USA, a subsidiary of Glenmark Generics, has received ANDA approval from USFDA for Hydralazine Hydrochloride tablets. The product will be available in dosages of 10mg, 25mg, 50mg and 100mg. The company will start marketing and shipping the product within US market soon.
Hydralazine Hydrochloride tablets are used for the treatment of essential hypertension. Glenmark Generics is a subsidiary of Glenmark Pharmaceuticals.
Glenmark Generics Inc is also exploring external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.